Clinical Trial Update: Delivering tAN to Reduce HMB: The LUNA Study [NA]

View source ↗

Summary

Clinical trial update for the LUNA study evaluating the delivery of tAN to reduce heavy menstrual bleeding; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding

Drugs mentioned

• tAN®

Snippet

Sponsor: Spark Biomedical, Inc. | Conditions: Heavy Menstrual Bleeding | NA | Status: RECRUITING